Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AdaptHealth (AHCO) Operating Expenses (2018 - 2025)

AdaptHealth has reported Operating Expenses over the past 8 years, most recently at $919.9 million for Q4 2025.

  • Quarterly results put Operating Expenses at $919.9 million for Q4 2025, up 21.21% from a year ago — trailing twelve months through Dec 2025 was $3.2 billion (up 6.32% YoY), and the annual figure for FY2025 was $3.2 billion, up 6.32%.
  • Operating Expenses for Q4 2025 was $919.9 million at AdaptHealth, up from $758.6 million in the prior quarter.
  • Over the last five years, Operating Expenses for AHCO hit a ceiling of $1.3 billion in Q3 2023 and a floor of $466.7 million in Q1 2021.
  • Median Operating Expenses over the past 5 years was $742.2 million (2024), compared with a mean of $750.1 million.
  • Biggest five-year swings in Operating Expenses: skyrocketed 154.73% in 2021 and later plummeted 41.32% in 2024.
  • AdaptHealth's Operating Expenses stood at $643.6 million in 2021, then rose by 17.08% to $753.6 million in 2022, then surged by 42.8% to $1.1 billion in 2023, then dropped by 29.47% to $759.0 million in 2024, then rose by 21.21% to $919.9 million in 2025.
  • The last three reported values for Operating Expenses were $919.9 million (Q4 2025), $758.6 million (Q3 2025), and $753.3 million (Q2 2025) per Business Quant data.